113 related articles for article (PubMed ID: 1839439)
1. Vascular and myocardial effects of amlodipine: an overview.
Nayler WG; Gu XH
Postgrad Med J; 1991; 67 Suppl 5():S41-3. PubMed ID: 1839439
[TBL] [Abstract][Full Text] [Related]
2. The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload.
Nayler WG
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S42-4. PubMed ID: 2467127
[TBL] [Abstract][Full Text] [Related]
3. End-organ involvement and calcium antagonist therapy: animal studies.
Nayler WG
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S12-7. PubMed ID: 7603072
[TBL] [Abstract][Full Text] [Related]
4. The unique binding properties of amlodipine: a long-acting calcium antagonist.
Nayler WG; Gu XH
J Hum Hypertens; 1991 Aug; 5 Suppl 1():55-9. PubMed ID: 1834847
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
[TBL] [Abstract][Full Text] [Related]
6. Vascular injury: mechanisms and manifestations.
Nayler WG
Am J Med; 1991 Apr; 90(4B):8S-13S. PubMed ID: 1826808
[TBL] [Abstract][Full Text] [Related]
7. The pharmacological profile of amlodipine in relation to ischaemic heart disease.
Burges RA
Postgrad Med J; 1991; 67 Suppl 3():S9-15. PubMed ID: 1836872
[TBL] [Abstract][Full Text] [Related]
8. Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats.
Janssen BJ; Kam KL; Smits JF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):414-21. PubMed ID: 11692224
[TBL] [Abstract][Full Text] [Related]
9. Amlodipine: a once daily calcium antagonist.
Burges RA
J Hum Hypertens; 1991 Aug; 5 Suppl 1():49-54. PubMed ID: 1834846
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
11. Protecting the vasculature: an eye toward the future.
Nayler WG; Gu XH
Am J Cardiol; 1990 Nov; 66(18):23H-27H. PubMed ID: 2147359
[TBL] [Abstract][Full Text] [Related]
12. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
[TBL] [Abstract][Full Text] [Related]
13. Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine.
Opie LH
Postgrad Med J; 1991; 67 Suppl 5():S2-8. PubMed ID: 1666430
[TBL] [Abstract][Full Text] [Related]
14. Efficient inhibition of the development of cardiac remodeling by a long-acting calcium antagonist amlodipine.
Yamazaki T; Komuro I; Zou Y; Kudoh S; Shiojima I; Mizuno T; Hiroi Y; Nagai R; Yazaki Y
Hypertension; 1998 Jan; 31(1):32-8. PubMed ID: 9449387
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure and alpha-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca.
Civantos B; Aleixandre A
Eur J Pharmacol; 2004 Apr; 489(1-2):101-10. PubMed ID: 15063161
[TBL] [Abstract][Full Text] [Related]
16. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
Pruneau D; Roy F; Brown NL
Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
Choi SM; Seo MJ; Kang KK; Kim JH; Ahn BO; Yoo M
Arch Pharm Res; 2009 Mar; 32(3):353-8. PubMed ID: 19387578
[TBL] [Abstract][Full Text] [Related]
18. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
Am J Cardiol; 1989 Nov; 64(17):21I-34I. PubMed ID: 2530884
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.
Shinyama H; Nagai H; Kawamura T; Narita Y; Uchida T; Watanabe M; Kagitani Y
J Pharmacol Exp Ther; 1995 Feb; 272(2):911-9. PubMed ID: 7853209
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors.
Yamada S; Sugimoto N; Uchida S; Deguchi Y; Kimura R
J Cardiovasc Pharmacol; 1994 Mar; 23(3):466-72. PubMed ID: 7515992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
